Benzoquinone, a leukemogenic metabolite of benzene, catalytically inhibits the protein tyrosine phosphatase PTPN2 and alters STAT1 signaling.

benzene bioactivation cancer carcinogen carcinogenesis cell signaling covalent adduct enzyme inactivation enzyme inhibition leukemia leukemogenesis metabolic activation protein tyrosine phosphatase non-receptor type 2 (PTPN2) tyrosine-protein phosphatase (tyrosine phosphatase)

Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
16 08 2019
Historique:
received: 29 03 2019
revised: 21 06 2019
pubmed: 30 6 2019
medline: 24 3 2020
entrez: 29 6 2019
Statut: ppublish

Résumé

Protein tyrosine phosphatase, nonreceptor type 2 (PTPN2) is mainly expressed in hematopoietic cells, where it negatively regulates growth factor and cytokine signaling. PTPN2 is an important regulator of hematopoiesis and immune/inflammatory responses, as evidenced by loss-of-function mutations of

Identifiants

pubmed: 31248982
pii: S0021-9258(20)30135-6
doi: 10.1074/jbc.RA119.008666
pmc: PMC6699853
pii:
doi:

Substances chimiques

Benzoquinones 0
Neoplasm Proteins 0
STAT1 Transcription Factor 0
STAT1 protein, human 0
quinone 3T006GV98U
PTPN2 protein, human EC 3.1.3.48
Protein Tyrosine Phosphatase, Non-Receptor Type 2 EC 3.1.3.48
Benzene J64922108F

Banques de données

PDB
['1L8K']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12483-12494

Informations de copyright

© 2019 Duval et al.

Références

Toxicol Sci. 2000 Jun;55(2):327-34
pubmed: 10828264
Biochemistry. 2004 Apr 13;43(14):4294-303
pubmed: 15065873
Mutat Res. 2004 Mar;566(2):99-130
pubmed: 15164977
Biochemistry. 2004 Jun 15;43(23):7563-74
pubmed: 15182198
Methods. 2005 Jan;35(1):2-8
pubmed: 15588980
Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4718-23
pubmed: 15774585
Toxicology. 2005 May 5;209(3):279-87
pubmed: 15795063
Chem Res Toxicol. 2005 Apr;18(4):761-70
pubmed: 15833037
Chem Biol Interact. 2005 May 30;153-154:103-9
pubmed: 15935805
Chem Biol Interact. 2005 May 30;153-154:207-16
pubmed: 15935818
Free Radic Res. 2005 Jun;39(6):649-57
pubmed: 16036343
J Biol Chem. 1991 Jan 15;266(2):689-92
pubmed: 1702437
Nat Rev Mol Cell Biol. 2006 Nov;7(11):833-46
pubmed: 17057753
Blood. 2007 May 15;109(10):4220-8
pubmed: 17234741
Biochem J. 2007 Feb 15;402(1):1-15
pubmed: 17238862
Biochemistry. 2007 Mar 13;46(10):2856-64
pubmed: 17298034
J Immunol. 2007 Apr 1;178(7):4284-95
pubmed: 17371985
Proteomics. 2007 Aug;7(15):2553-6
pubmed: 17610305
Chem Res Toxicol. 2007 Sep;20(9):1315-20
pubmed: 17655273
J Biol Chem. 2007 Nov 16;282(46):33396-404
pubmed: 17878162
Oncogene. 2007 Oct 15;26(47):6724-37
pubmed: 17934481
Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9368-72
pubmed: 19474293
J Clin Oncol. 2009 Sep 10;27(26):4422-32
pubmed: 19667270
Blood. 2010 Jan 14;115(2):261-4
pubmed: 19828700
Chem Biol Interact. 2010 Mar 19;184(1-2):86-93
pubmed: 20026094
Chem Biol Interact. 2010 Mar 19;184(1-2):259-68
pubmed: 20034485
Nat Genet. 2010 Jun;42(6):530-5
pubmed: 20473312
Hum Exp Toxicol. 2011 Jul;30(7):725-35
pubmed: 20729258
Hybridoma (Larchmt). 2010 Dec;29(6):481-8
pubmed: 21087101
Environ Health Perspect. 2011 May;119(5):628-34
pubmed: 21147609
Chem Biol Interact. 2011 Jun 30;192(1-2):155-9
pubmed: 21333640
Blood. 2011 Jun 30;117(26):7090-8
pubmed: 21551237
Haematologica. 2011 Nov;96(11):1723-7
pubmed: 21791476
J Biochem. 2011 Oct;150(4):345-56
pubmed: 21856739
Cell. 2011 Sep 2;146(5):826-40
pubmed: 21884940
Chem Res Toxicol. 2012 Jul 16;25(7):1303-15
pubmed: 22540379
PLoS One. 2012;7(5):e36703
pubmed: 22590589
FEBS J. 2013 Jan;280(2):413-31
pubmed: 22682070
Int J Environ Res Public Health. 2012 Aug;9(8):2875-93
pubmed: 23066403
Chem Res Toxicol. 2013 Jan 18;26(1):112-23
pubmed: 23237669
Gene Regul Syst Bio. 2013 Mar 26;7:41-56
pubmed: 23645984
Leuk Res. 2013 Sep;37(9):1150-5
pubmed: 23759247
Ann N Y Acad Sci. 2014 Mar;1310:7-31
pubmed: 24495159
Mutat Res Rev Mutat Res. 2014 Apr 13;:null
pubmed: 24731989
JAKSTAT. 2014 Jan 1;3(1):e28087
pubmed: 24778927
Adv Biol Regul. 2014 Sep;56:30-44
pubmed: 24931719
Cell Metab. 2014 Jul 1;20(1):85-102
pubmed: 24954415
J Immunol Res. 2014;2014:937987
pubmed: 25202711
Molecules. 2014 Sep 17;19(9):14902-18
pubmed: 25232709
Sci Rep. 2015 Jun 04;5:10750
pubmed: 26040922
PLoS One. 2015 Oct 07;10(10):e0140013
pubmed: 26444872
J Chem Theory Comput. 2016 Jan 12;12(1):281-96
pubmed: 26584231
Ann Clin Lab Sci. 2015 Fall;45(5):487-94
pubmed: 26586698
Cytokine. 2016 Jun;82:52-7
pubmed: 26817397
Dalton Trans. 2016 Apr 7;45(13):5455-9
pubmed: 26961812
Free Radic Biol Med. 2016 Aug;97:148-157
pubmed: 27212016
Chem Res Toxicol. 2017 Jan 17;30(1):13-37
pubmed: 27617882
J Immunol. 2017 Mar 1;198(5):1865-1874
pubmed: 28122962
Lancet Oncol. 2017 Dec;18(12):1574-1575
pubmed: 29107678
Crit Rev Toxicol. 2018 Mar;48(3):217-251
pubmed: 29243948
Environ Res. 2018 Oct;166:91-99
pubmed: 29883905
Cancer Res. 1993 Mar 1;53(5):1023-6
pubmed: 8439949
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Environ Health Perspect. 1996 Dec;104 Suppl 6:1319-23
pubmed: 9118913
J Exp Med. 1997 Aug 29;186(5):683-93
pubmed: 9271584

Auteurs

Romain Duval (R)

Université de Paris, BFA, UMR 8251, CNRS, F-75013 Paris, France.

Linh-Chi Bui (LC)

Université de Paris, BFA, UMR 8251, CNRS, F-75013 Paris, France.

Cécile Mathieu (C)

Université de Paris, BFA, UMR 8251, CNRS, F-75013 Paris, France.

Qing Nian (Q)

Université de Paris, BFA, UMR 8251, CNRS, F-75013 Paris, France.

Jérémy Berthelet (J)

Université de Paris, BFA, UMR 8251, CNRS, F-75013 Paris, France.

Ximing Xu (X)

Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.

Iman Haddad (I)

ESPCI Paris, PSL Université, USR 3149, CNRS, F-75005 Paris, France.

Joelle Vinh (J)

ESPCI Paris, PSL Université, USR 3149, CNRS, F-75005 Paris, France.

Jean-Marie Dupret (JM)

Université de Paris, BFA, UMR 8251, CNRS, F-75013 Paris, France.

Florent Busi (F)

Université de Paris, BFA, UMR 8251, CNRS, F-75013 Paris, France.

Fabien Guidez (F)

Université de Paris, Institut de Recherche Saint-Louis, UMRS 1131, INSERM, F-75010 Paris, France.

Christine Chomienne (C)

Université de Paris, Institut de Recherche Saint-Louis, UMRS 1131, INSERM, F-75010 Paris, France; Service de Biologie Cellulaire, Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Saint Louis, F-75010 Paris, France.

Fernando Rodrigues-Lima (F)

Université de Paris, BFA, UMR 8251, CNRS, F-75013 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH